Bacterial Endocarditis

• EMA approval · 2025-11-07
  EMA Authorised: Cubicin (daptomycin)

  The European Medicines Agency authorised Cubicin (daptomycin) for Gram-positive bacterial infections including bacteremia, soft tissue infec…

• CLINICAL_TRIALS trial_result · 2025-09-26
  Clinical Trial Update: Anemia in Patients With Endocarditis

  This clinical trial update reports on a completed study investigating anemia in patients with bacterial endocarditis conducted by Rigshospit…

• CLINICAL_TRIALS research · 2024-10-01
  Clinical Trial Update: Fosfomycin I.v. for Treatment of Severely Infected Patients

  An intravenous fosfomycin trial is recruiting to evaluate its use in severely infected patients across multiple bacterial infection indicati…

• CLINICAL_TRIALS trial_result · 2017-02-13
  Clinical Trial Update: Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus [Phase 3]

  Phase 3 trial evaluating daptomycin for infective endocarditis or bacteremia due to Staphylococcus aureus has completed.